J Am Acad Audiol
DOI: 10.1055/s-0044-1790278
Research Article

COVID-19 and Hearing: Pure Tone, Speech, and High-Frequency Audiometry

1   Department of Audiology, Gazi University, Faculty of Health Sciences, Ankara, Türkiye
,
2   Department of Otorhinolaryngology, Gazi University, Faculty of Medicine, Ankara, Türkiye
,
2   Department of Otorhinolaryngology, Gazi University, Faculty of Medicine, Ankara, Türkiye
› Author Affiliations

Abstract

Background Coronavirus disease 2019 (COVID-19) and its effects on hearing performance have been an interesting topic for researchers recently.

Purpose The objective of this study was to assess the audiological profile of people affected by COVID-19 and also to compare them with a control group who has never had COVID-19.

Research Design An experimental study.

Study Sample The study group consisted of 54 participants, aged 18 to 60, who were diagnosed with COVID-19 by polymerase chain reaction and recovered at least 2 months prior to audiological assessment. The control group consisted of 60 subjects in the same age range who did not have a history of COVID-19 or hearing loss.

Data Collection and Analysis Post-COVID audiological data were compared. The pre-COVID-19 audiological data of 43 subjects in the study group were also compared with their post-COVID-19 data. All participants were evaluated with pure tone audiometry, acoustic immittancemetry, speech audiometry, and high-frequency audiometry.

Results Pure tone hearing thresholds, speech recognition and discrimination scores, and high-frequency hearing thresholds were all statistically different between the study and control groups (p < 0.05). There were statistically significant differences between the study group's pure tone hearing thresholds before and after COVID-19 (p < 0.05).

Conclusion COVID-19 can adversely affect hearing performance. Further studies including auditory brainstem response, otoacoustic emissions, and similar cross-check tests are needed to reveal further effects of COVID-19 on hearing.

Data Availability Statement

The research data associated with a paper are available on the corresponding author and the data can be shared when necessary.




Publication History

Received: 07 August 2023

Accepted: 19 November 2023

Article published online:
02 December 2024

© 2024. American Academy of Audiology. This article is published by Thieme.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 
  • References

  • 1 Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus disease (COVID-19)–statistics and research. Our World in Data 2020;4
  • 2 Kim G-U, Kim M-J, Ra SH. et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect 2020; 26 (07) 948.e1-948.e3
  • 3 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
  • 4 Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S. et al Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 2020; 95 (05) e601-e605
  • 5 Lima MA, Silva MTT, Soares CN. et al Peripheral facial nerve palsy associated with COVID-19. Journal of Neurovirology 2020; 26: 941-944
  • 6 Jafari Z, Kolb BE, Mohajerani MH. Hearing loss, tinnitus, and dizziness in COVID-19: a systematic review and meta-analysis. Can J Neurol Sci 2022; 49 (02) 184-195
  • 7 Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep 2020; 13 (11) e238419
  • 8 Viola P, Ralli M, Pisani D. et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol 2021; 278 (10) 3725-3730
  • 9 Clark JG. Uses and abuses of hearing loss classification. ASHA 1981; 23 (07) 493-500
  • 10 Jerger J, Anthony L, Jerger S, Mauldin L. Studies in impedance audiometry. 3. Middle ear disorders. Arch Otolaryngol 1974; 99 (03) 165-171
  • 11 Öztürk B, Kavruk H, Aykul A. Audiological findings in individuals diagnosed with COVID-19. Am J Otolaryngol 2022; 43 (03) 103428
  • 12 Tan M, Cengiz DU, Demir İ. et al. Effects of Covid-19 on the audio-vestibular system. Am J Otolaryngol 2022; 43 (01) 103173
  • 13 Cure E, Cure MC. COVID-19 may predispose to thrombosis by affecting both vascular endothelium and platelets. Clin Appl Thromb Hemost 2020; 26: 10 76029620933945
  • 14 Singh SP, Pritam M, Pandey B, Yadav TP. Microstructure, pathophysiology, and potential therapeutics of COVID-19: a comprehensive review. J Med Virol 2021; 93 (01) 275-299
  • 15 Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 2021; 49 (02) 199-213
  • 16 Kilic O, Kalcioglu MT, Cag Y. et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis 2020; 97: 208-211
  • 17 Degen C, Lenarz T, Willenborg K. eds. Acute Profound Sensorineural Hearing Loss after COVID-19 Pneumonia. Mayo Clinic Proceedings;; Elsevier;; 2020
  • 18 Dusan M, Milan S, Nikola D. COVID-19 caused hearing loss. Eur Arch Otorhinolaryngol 2022; 279 (05) 2363-2372
  • 19 Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol 2020; 41 (03) 102483
  • 20 Rahimi V, Asiyabar MK, Rouhbakhsh N. Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement. J Laryngol Otol 2021; 135 (05) 464-466
  • 21 Gedik Ö, Hüsam H, Başöz M, Tas N, Aksoy F. The effect of coronavirus disease 2019 on the hearing system. J Laryngol Otol 2021; 135 (09) 810-814
  • 22 Prayuenyong P, Kasbekar AV, Baguley DM. Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19 treatment: a mini-review. Front Public Health 2020; 8: 252
  • 23 World Health Organization. Living guidance for clinical management of COVID-19: living guidance. World Health Organization; 2021
  • 24 Emekci T, Dündar MA, Kirazlı G. et al. Evaluation of the efferent auditory system in COVID-19 adult patients. Acta Otolaryngol 2022; 142 (06) 509-514
  • 25 Rahimi V, Rouhbakhsh N, Manshadi SAD. Slight high-frequency hearing loss, effect of COVID-19 or hydroxychloroquine usage?. Otol Neurotol 2022; 43 (09) e944-e950
  • 26 Alves de Sousa F, Pinto Costa R, Xará S, Nóbrega Pinto A, Almeida E Sousa C. SARS-CoV-2 and hearing: an audiometric analysis of COVID-19 hospitalized patients. J Otol 2021; 16 (03) 158-164
  • 27 Dharmarajan S, Bharathi MB, Sivapuram K. et al. Hearing loss-a camouflaged manifestation of COVID 19 infection. Indian J Otolaryngol Head Neck Surg 2021; 73 (04) 494-498